3.22.2.2 html 195 271 1 false 59 0 false 5 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.rvlpharmaceuticals.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - Unaudited Condensed Consolidated Balance Sheets Sheet http://www.rvlpharmaceuticals.com/role/StatementUnauditedCondensedConsolidatedBalanceSheets Unaudited Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Unaudited Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://www.rvlpharmaceuticals.com/role/StatementUnauditedCondensedConsolidatedBalanceSheetsParentheticals Unaudited Condensed Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 00200 - Statement - Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.rvlpharmaceuticals.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 00300 - Statement - Unaudited Condensed Consolidated Statements of Changes in Shareholders' Equity Sheet http://www.rvlpharmaceuticals.com/role/StatementUnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity Unaudited Condensed Consolidated Statements of Changes in Shareholders' Equity Statements 5 false false R6.htm 00400 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows Sheet http://www.rvlpharmaceuticals.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows Unaudited Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 10101 - Disclosure - Organization and Nature of Operations Sheet http://www.rvlpharmaceuticals.com/role/DisclosureOrganizationAndNatureOfOperations Organization and Nature of Operations Notes 7 false false R8.htm 10201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Sheet http://www.rvlpharmaceuticals.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies Basis of Presentation and Summary of Significant Accounting Policies Notes 8 false false R9.htm 10301 - Disclosure - Liquidity Sheet http://www.rvlpharmaceuticals.com/role/DisclosureLiquidity Liquidity Notes 9 false false R10.htm 10401 - Disclosure - Discontinued Operations Sheet http://www.rvlpharmaceuticals.com/role/DisclosureDiscontinuedOperations Discontinued Operations Notes 10 false false R11.htm 10501 - Disclosure - Revenues Sheet http://www.rvlpharmaceuticals.com/role/DisclosureRevenues Revenues Notes 11 false false R12.htm 10601 - Disclosure - Accounts Receivable and Other Receivables Sheet http://www.rvlpharmaceuticals.com/role/DisclosureAccountsReceivableAndOtherReceivables Accounts Receivable and Other Receivables Notes 12 false false R13.htm 10701 - Disclosure - Accrued Liabilities Sheet http://www.rvlpharmaceuticals.com/role/DisclosureAccruedLiabilities Accrued Liabilities Notes 13 false false R14.htm 10801 - Disclosure - Financing Arrangements Sheet http://www.rvlpharmaceuticals.com/role/DisclosureFinancingArrangements Financing Arrangements Notes 14 false false R15.htm 10901 - Disclosure - Share-Based Compensation Sheet http://www.rvlpharmaceuticals.com/role/DisclosureShareBasedCompensation Share-Based Compensation Notes 15 false false R16.htm 11001 - Disclosure - Earnings (Loss) Per Ordinary Share Sheet http://www.rvlpharmaceuticals.com/role/DisclosureEarningsLossPerOrdinaryShare Earnings (Loss) Per Ordinary Share Notes 16 false false R17.htm 11101 - Disclosure - Customer Concentration Sheet http://www.rvlpharmaceuticals.com/role/DisclosureCustomerConcentration Customer Concentration Notes 17 false false R18.htm 11201 - Disclosure - Commitments and Contingencies Sheet http://www.rvlpharmaceuticals.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 18 false false R19.htm 11301 - Disclosure - Income Taxes Sheet http://www.rvlpharmaceuticals.com/role/DisclosureIncomeTaxes Income Taxes Notes 19 false false R20.htm 11401 - Disclosure - Financial Instruments and Fair Value Measurements Sheet http://www.rvlpharmaceuticals.com/role/DisclosureFinancialInstrumentsAndFairValueMeasurements Financial Instruments and Fair Value Measurements Notes 20 false false R21.htm 11501 - Disclosure - Shareholders' Equity Sheet http://www.rvlpharmaceuticals.com/role/DisclosureShareholdersEquity Shareholders' Equity Notes 21 false false R22.htm 11601 - Disclosure - Restructuring Expenses Sheet http://www.rvlpharmaceuticals.com/role/DisclosureRestructuringExpenses Restructuring Expenses Notes 22 false false R23.htm 11701 - Disclosure - Indefinite-Lived Intangible Assets Sheet http://www.rvlpharmaceuticals.com/role/DisclosureIndefiniteLivedIntangibleAssets Indefinite-Lived Intangible Assets Notes 23 false false R24.htm 11801 - Disclosure - Subsequent Events Sheet http://www.rvlpharmaceuticals.com/role/DisclosureSubsequentEvents Subsequent Events Notes 24 false false R25.htm 20202 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies Basis of Presentation and Summary of Significant Accounting Policies (Policies) Policies http://www.rvlpharmaceuticals.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies 25 false false R26.htm 30203 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables Basis of Presentation and Summary of Significant Accounting Policies (Tables) Tables http://www.rvlpharmaceuticals.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies 26 false false R27.htm 30403 - Disclosure - Discontinued Operations (Tables) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureDiscontinuedOperationsTables Discontinued Operations (Tables) Tables http://www.rvlpharmaceuticals.com/role/DisclosureDiscontinuedOperations 27 false false R28.htm 30503 - Disclosure - Revenues (Tables) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureRevenuesTables Revenues (Tables) Tables http://www.rvlpharmaceuticals.com/role/DisclosureRevenues 28 false false R29.htm 30603 - Disclosure - Accounts Receivable and Other Receivables (Tables) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureAccountsReceivableAndOtherReceivablesTables Accounts Receivable and Other Receivables (Tables) Tables http://www.rvlpharmaceuticals.com/role/DisclosureAccountsReceivableAndOtherReceivables 29 false false R30.htm 30703 - Disclosure - Accrued Liabilities (Tables) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureAccruedLiabilitiesTables Accrued Liabilities (Tables) Tables http://www.rvlpharmaceuticals.com/role/DisclosureAccruedLiabilities 30 false false R31.htm 30803 - Disclosure - Financing Arrangements (Tables) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureFinancingArrangementsTables Financing Arrangements (Tables) Tables http://www.rvlpharmaceuticals.com/role/DisclosureFinancingArrangements 31 false false R32.htm 30903 - Disclosure - Share-Based Compensation (Tables) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureShareBasedCompensationTables Share-Based Compensation (Tables) Tables http://www.rvlpharmaceuticals.com/role/DisclosureShareBasedCompensation 32 false false R33.htm 31003 - Disclosure - Earnings (Loss) Per Ordinary Share (Tables) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureEarningsLossPerOrdinaryShareTables Earnings (Loss) Per Ordinary Share (Tables) Tables http://www.rvlpharmaceuticals.com/role/DisclosureEarningsLossPerOrdinaryShare 33 false false R34.htm 31303 - Disclosure - Income Taxes (Tables) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureIncomeTaxesTables Income Taxes (Tables) Tables http://www.rvlpharmaceuticals.com/role/DisclosureIncomeTaxes 34 false false R35.htm 31403 - Disclosure - Financial Instruments and Fair Value Measurements (Tables) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsTables Financial Instruments and Fair Value Measurements (Tables) Tables http://www.rvlpharmaceuticals.com/role/DisclosureFinancialInstrumentsAndFairValueMeasurements 35 false false R36.htm 40101 - Disclosure - Organization and Nature of Operations (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureOrganizationAndNatureOfOperationsDetails Organization and Nature of Operations (Details) Details http://www.rvlpharmaceuticals.com/role/DisclosureOrganizationAndNatureOfOperations 36 false false R37.htm 40201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Supplemental Cash Flow Disclosures (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSupplementalCashFlowDisclosuresDetails Basis of Presentation and Summary of Significant Accounting Policies - Supplemental Cash Flow Disclosures (Details) Details 37 false false R38.htm 40301 - Disclosure - Liquidity (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureLiquidityDetails Liquidity (Details) Details http://www.rvlpharmaceuticals.com/role/DisclosureLiquidity 38 false false R39.htm 40401 - Disclosure - Discontinued Operations (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureDiscontinuedOperationsDetails Discontinued Operations (Details) Details http://www.rvlpharmaceuticals.com/role/DisclosureDiscontinuedOperationsTables 39 false false R40.htm 40402 - Disclosure - Discontinued Operations - Cash flows (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureDiscontinuedOperationsCashFlowsDetails Discontinued Operations - Cash flows (Details) Details 40 false false R41.htm 40403 - Disclosure - Discontinued Operations - Gain on Sale (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureDiscontinuedOperationsGainOnSaleDetails Discontinued Operations - Gain on Sale (Details) Details 41 false false R42.htm 40501 - Disclosure - Revenues (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureRevenuesDetails Revenues (Details) Details http://www.rvlpharmaceuticals.com/role/DisclosureRevenuesTables 42 false false R43.htm 40502 - Disclosure - Revenues - Adjustment to gross product sales (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureRevenuesAdjustmentToGrossProductSalesDetails Revenues - Adjustment to gross product sales (Details) Details 43 false false R44.htm 40503 - Disclosure - Revenues - Narrative (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureRevenuesNarrativeDetails Revenues - Narrative (Details) Details 44 false false R45.htm 40601 - Disclosure - Accounts Receivable and Other Receivables (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureAccountsReceivableAndOtherReceivablesDetails Accounts Receivable and Other Receivables (Details) Details http://www.rvlpharmaceuticals.com/role/DisclosureAccountsReceivableAndOtherReceivablesTables 45 false false R46.htm 40701 - Disclosure - Accrued Liabilities (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureAccruedLiabilitiesDetails Accrued Liabilities (Details) Details http://www.rvlpharmaceuticals.com/role/DisclosureAccruedLiabilitiesTables 46 false false R47.htm 40801 - Disclosure - Financing Arrangements - Components (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureFinancingArrangementsComponentsDetails Financing Arrangements - Components (Details) Details 47 false false R48.htm 40802 - Disclosure - Financing Arrangements - Maturities of long-term debt and financing obligations (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureFinancingArrangementsMaturitiesOfLongTermDebtAndFinancingObligationsDetails Financing Arrangements - Maturities of long-term debt and financing obligations (Details) Details 48 false false R49.htm 40803 - Disclosure - Financing Arrangements (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureFinancingArrangementsDetails Financing Arrangements (Details) Details http://www.rvlpharmaceuticals.com/role/DisclosureFinancingArrangementsTables 49 false false R50.htm 40901 - Disclosure - Share-Based Compensation (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureShareBasedCompensationDetails Share-Based Compensation (Details) Details http://www.rvlpharmaceuticals.com/role/DisclosureShareBasedCompensationTables 50 false false R51.htm 41001 - Disclosure - Earnings (Loss) Per Ordinary Share (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureEarningsLossPerOrdinaryShareDetails Earnings (Loss) Per Ordinary Share (Details) Details http://www.rvlpharmaceuticals.com/role/DisclosureEarningsLossPerOrdinaryShareTables 51 false false R52.htm 41101 - Disclosure - Customer Concentration (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureCustomerConcentrationDetails Customer Concentration (Details) Details http://www.rvlpharmaceuticals.com/role/DisclosureCustomerConcentration 52 false false R53.htm 41201 - Disclosure - Commitments and Contingencies - Legal (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureCommitmentsAndContingenciesLegalDetails Commitments and Contingencies - Legal (Details) Details 53 false false R54.htm 41301 - Disclosure - Income Taxes (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureIncomeTaxesDetails Income Taxes (Details) Details http://www.rvlpharmaceuticals.com/role/DisclosureIncomeTaxesTables 54 false false R55.htm 41401 - Disclosure - Financial Instruments and Fair Value Measurements (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetails Financial Instruments and Fair Value Measurements (Details) Details http://www.rvlpharmaceuticals.com/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsTables 55 false false R56.htm 41402 - Disclosure - Financial Instruments and Fair Value Measurements - Schedule of valuation techniques and unobservable inputs (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfValuationTechniquesAndUnobservableInputsDetails Financial Instruments and Fair Value Measurements - Schedule of valuation techniques and unobservable inputs (Details) Details 56 false false R57.htm 41403 - Disclosure - Financial Instruments and Fair Value Measurements -Schedule of financial liabilities subject to Level 3 fair value measurements on a recurring basis (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFinancialLiabilitiesSubjectToLevel3FairValueMeasurementsOnRecurringBasisDetails Financial Instruments and Fair Value Measurements -Schedule of financial liabilities subject to Level 3 fair value measurements on a recurring basis (Details) Details 57 false false R58.htm 41501 - Disclosure - Shareholders' Equity - Equity Offering (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureShareholdersEquityEquityOfferingDetails Shareholders' Equity - Equity Offering (Details) Details 58 false false R59.htm 41601 - Disclosure - Restructuring Expenses (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureRestructuringExpensesDetails Restructuring Expenses (Details) Details http://www.rvlpharmaceuticals.com/role/DisclosureRestructuringExpenses 59 false false R60.htm 41701 - Disclosure - Indefinite-Lived Intangible Assets (Details) Sheet http://www.rvlpharmaceuticals.com/role/DisclosureIndefiniteLivedIntangibleAssetsDetails Indefinite-Lived Intangible Assets (Details) Details http://www.rvlpharmaceuticals.com/role/DisclosureIndefiniteLivedIntangibleAssets 60 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 20 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:CommonStockOtherSharesOutstanding, us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:EarningsPerShareDiluted, us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare, us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare, us-gaap:PreferredStockSharesOutstanding, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding - rvlp-20220930x10q.htm 9 [ix-0514-Hidden-Fact-Not-Referenced] WARN: 2 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:CommitmentsAndContingencies - rvlp-20220930x10q.htm 9 rvlp-20220930x10q.htm rvlp-20220930.xsd rvlp-20220930_cal.xml rvlp-20220930_def.xml rvlp-20220930_lab.xml rvlp-20220930_pre.xml rvlp-20220930xex31d1.htm rvlp-20220930xex32d1.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true